Acarbose insulin glargine combined on treatment of elderly diabetic

Objective To investigate insulin glargine combined acarbose treatment of senile diabetes therapy. Methods 246 cases type 2 diabetes were treated in out - patient or in hospital from January 2008 to January 2010 who were randomly divided into treatment group( 126 ) and control group (120). Treatment group patients treated with insulin glargine combined acarbose treatment, and control group were treated by Protamine zinc mixed recombinant human insulin injection treatment;To observe clinical effects and β -cell function. Results Comparison of two groups of blood glucose time, P ＜ 0. 05; Two groups of insulin daily dose, the incidence of hypoglycemia,P ＜ 0. 01 ;Treatment before and after the C peptide + insulin release test comparison, P ＜ 0. 05; Conclusion Insulin glargine combined acarbose can achieve good control of blood glucose and reducing insulin dosage, reducing the incidence of low blood sugar, which an improvement of β cell function. It is a good drug compliance and treatment program in elderly type 2 diabetes. Key words: Insulin glargine combined acarbose; Senile diabetes; Efficacy